This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

pms-Zopiclone (2015-09-24)

Starting date:
September 24, 2015
Posting date:
October 6, 2015
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-55146

Affected Products

pms-Zopiclone

Reason

These lots may contain oversized tablets exceeding the maximum recommended daily dose of 7.5 mg.

Depth of distribution

Wholesalers and pharmacies in Canada

Affected products

pms-Zopiclone

DIN, NPN, DIN-HIM
DIN 02240606
Dosage form

Tablet

Strength

7.5 mg

Lot or serial number
  • 470882
  • 470884
  • 488194
  • 488195
Companies
Recalling Firm
Pharmascience Inc.
8580 L'Esplanade Ave.
Montreal
H2P 2R8
Quebec
CANADA
Marketing Authorization Holder
Pharmascience Inc.
8580 L'Esplanade Ave.
Montreal
H2P 2R8
Quebec
CANADA

Date modified: